Exercise and Weight Control

July 18, 2019 updated by: James Roemmich, USDA Grand Forks Human Nutrition Research Center

Exercise and Weight Control: A Search for Biological and Neurobehavioral Compensatory Mechanisms That Defend Against Exercise-Induced Negative Energy Balance

The purpose of this study is to research the effects of exercise on calories eaten and expended. The investigator expects to find out whether subjects change their eating and activity behaviors when starting an exercise program.

Study Overview

Study Type

Interventional

Enrollment (Actual)

29

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • North Dakota
      • Grand Forks, North Dakota, United States, 58203
        • USDA Grand Forks Human Nutrition Reserach Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 18 to 40 years old
  • BMI of 25.0 - 35 kg/m2
  • willing to consent to study conditions
  • not taking medications that affects energy expenditure or eating
  • not using tobacco or nicotine products
  • no food allergies or limitations to eating certain food that would prohibit them from eating the study foods
  • not be dieting to lose weight
  • no major health problems
  • cannot have known cardiovascular, pulmonary or metabolic disease
  • cannot be regularly exercising in an aerobic manner more than twice per week
  • must have a liking of at least 5 out of 10 for 75% of the study foods

Exclusion Criteria:

  • < 18 or > 40 years old
  • BMI < 25 or >35 kg/m2
  • currently pregnant or trying to become pregnant, or lactating
  • currently using tobacco or nicotine
  • taking medication that affects energy expenditure or eating
  • food allergies to foods used in the study
  • regularly exercising in an aerobic manner more than twice per week
  • major health problems

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Exercise Energy Expenditure 300 kcal/day
Subjects will be randomly assigned to this group and will exercise energy expenditure of 300 kcal/day.
Experimental: Exercise Energy Expenditure 600 kcal/day
Subjects will be randomly assigned to this group and will exercise energy expenditure of 600 kcal/day.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Negative Energy Balance as assessed by changes in adipose tissue
Time Frame: End Training (weeks 10-12)
Whether participants were able to maintain a negative energy balance will be assessed by pre-post changes in stored adipose tissue, as assessed by a dual-energy x-ray absorptiometry scan (DEXA).
End Training (weeks 10-12)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in relative reinforcing value (RRV) of food
Time Frame: Pre-intervention (week 0) and End Training (weeks 10-12)
RRV of food will be assessed by evaluating the number of responses (mouse button presses) a participant is willing to complete to gain access to food or an alternative sedentary activity.
Pre-intervention (week 0) and End Training (weeks 10-12)
Average daily calories consumed as assessed by dietary recall
Time Frame: Pre-intervention (week 0) and End Training (weeks 10-12)
On two weekdays and one weekend day, participants will fill out the Automated Self-Administered 24-Hour Dietary Recall (ASA24) to estimate dietary intake (total energy, grams carbohydrates, fat, protein, alcohol).
Pre-intervention (week 0) and End Training (weeks 10-12)
Pre-post intervention changes in Ghrelin plasma levels
Time Frame: Pre-intervention (week 0) and End Training (weeks 10-12)
Participants will provide a fasting blood sample collected in ethylenediaminetetraacetic acid (EDTA)-coated and serum tubes. Changes in acylated Ghrelin will be measured via enzyme-linked immunosorbent assay (ELISA).
Pre-intervention (week 0) and End Training (weeks 10-12)
Pre-post intervention changes in glucagon-like peptide 1 (GLP-1) plasma levels
Time Frame: Pre-intervention (week 0) and End Training (weeks 10-12)
Participants will provide a fasting blood sample collected in EDTA-coated and serum tubes. Changes in GLP-1 concentrations will be measured via ELISA.
Pre-intervention (week 0) and End Training (weeks 10-12)
Pre-post intervention changes in Ghrelin concentrations
Time Frame: Pre-intervention (week 0) and End Training (weeks 10-12)
Participants will provide a fasting blood sample collected in EDTA-coated and serum tubes. Changes in Ghrelin concentrations will be measured via ELISA.
Pre-intervention (week 0) and End Training (weeks 10-12)
Pre-post intervention changes in irisin concentrations
Time Frame: Pre-intervention (week 0) and End Training (weeks 10-12)
Participants will provide a fasting blood sample collected in EDTA-coated and serum tubes. Changes in irisin concentrations will be measured via ELISA.
Pre-intervention (week 0) and End Training (weeks 10-12)
Pre-post intervention changes in myostatin plasma levels
Time Frame: Pre-intervention (week 0) and End Training (weeks 10-12)
Participants will provide a fasting blood sample collected in EDTA-coated and serum tubes. Changes in myostatin levels will be measured via ELISA.
Pre-intervention (week 0) and End Training (weeks 10-12)
Change in relative reinforcing value (RRV) of physical activity
Time Frame: Pre-intervention (week 0) and End Training (weeks 10-12)
RRV of physical activity will be assessed by evaluating the number of responses (mouse button presses) a subject is willing to complete to gain access to physical activity or a sedentary alternative.
Pre-intervention (week 0) and End Training (weeks 10-12)
Change in minutes of sedentary behavior, as assessed by activity tracker
Time Frame: Pre-intervention (week 0) and End Training (weeks 10-12)
Minutes of sedentary behavior (non-exercise activity) will be assessed by having participants wear an Actigraph accelerometer for 7 days (minimum 10 hours per day) on the right hip.
Pre-intervention (week 0) and End Training (weeks 10-12)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: James Roemmich, PhD, USDA GFHNRC

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2016

Primary Completion (Actual)

November 1, 2016

Study Completion (Actual)

January 1, 2017

Study Registration Dates

First Submitted

May 22, 2014

First Submitted That Met QC Criteria

May 28, 2014

First Posted (Estimate)

June 2, 2014

Study Record Updates

Last Update Posted (Actual)

July 23, 2019

Last Update Submitted That Met QC Criteria

July 18, 2019

Last Verified

July 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Overweight

Clinical Trials on Exercise Energy Expenditure 300 kcal/day

3
Subscribe